Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · KRSNAA

KRSNAA

HealthcareHealthcare Services₹1656 cr market cap
₹515.80 ▲ +0.88% today As of 19 Nov 2026
52-week low ₹475.0052-week high ₹826.80

-38.2% from the 52-week high · +7.6% above the low

Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The company is headquartered in Pune, Maharashtra and currently employs 2,562 full-time employees. The company went IPO on 2021-08-16. The firm is primarily engaged in the business of providing diagnostic services all over India. The firm is providing radiology and pathology services for X-Ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. Its technology helps health care professionals diagnose and treat medical problems by imaging the interior of the human body. Its lab services offerings encompass a range of investigations from routine tests to specialized ones. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS), among others. The firm offers its services to public and private hospitals, medical colleges, and community health centers.

The short version. KRSNAA reported revenue of ₹271 crore for Sep 2026, up 31.6% from a year earlier. Net profit was ₹25 crore (up 4.2% year on year). Return on equity was 10.3% in Mar 2026. Promoter holding was 27.11% in Sep 2026, down 0.13 points over 8 quarters.

1 · The price

How has the stock traded?

KRSNAA trades 38.2% below its 52-week high and 7.6% above its 52-week low.

Change over period: —

1M-0.3%
3M-4.6%
6M-9.2%
1Y-37.2%

2 · The business

Is it growing?

Sales, year on year+31.6%

Sep 2026 revenue of ₹271 cr.

Profit, year on year+4.2%

Sep 2026 net profit of ₹25 cr.

Net margin9.1%

2.5 pts lower than a year earlier.

3-year growth17.8% profit

Revenue compounded at 17.2% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue271236193181206193186175
Net profit2517421524212119
Net margin %9.17.021.78.411.610.611.111.1
EPS (₹)7.585.112.864.77.386.336.46.01

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue773717620487455
Net profit10178576268
Net margin %13.110.89.212.815.0
EPS (₹)31.2724.0317.619.7821.78

3 · The quality

How well does it turn capital into profit?

Return on equity was 10.3% in Mar 2026; debt to equity is 0.55.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %10.38.87.08.4
Return on capital %10.613.09.710.8
EBITDA margin %31.329.025.328.0
Net margin %12.410.48.912.3

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR17.2%—
Profit CAGR17.8%—
Debt to equity0.55
Interest cover4.8x
Current ratio2.68
P/E ratio17.1

4 · The owners

Who holds it, and are they adding?

Promoter holding27.11%

Down 0.13 pts over 8 quarters.

Foreign institutions3.84%

Down 0.2 pts over 8 quarters.

Domestic institutions14.5%

Up 0.04 pts over 8 quarters.

Mutual fund schemes9

-1 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter27.2427.2427.1127.1127.1127.1127.1127.11-0.13
FII4.043.553.43.674.173.914.283.84-0.2
DII14.4614.2614.2414.9613.8613.8914.5114.5+0.04
Public54.2754.9455.2554.2654.8555.0854.0954.54+0.27

Mutual fund holdings · Oct 2026

9 schemes hold this stock

10 the month before.

  • Shriram Multi Sector Rotation Fund1.52% of NAV
  • TATA SMALL CAP FUND1.11% of NAV
  • Shriram Balanced Advantage Fund0.11% of NAV
  • Shriram Multi Asset Allocation Fund0.1% of NAV
  • Shriram Aggressive Hybrid Fund0.1% of NAV
  • Bandhan Small Cap Fund0.09% of NAV
  • Motilal Oswal BSE Healthcare ETF0.06% of NAV
  • Bandhan BSE Healthcare Index Fund0.06% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for KRSNAA are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about KRSNAA

What is the KRSNAA share price?

KRSNAA (KRSNAA) last closed at ₹515.80, up 0.88% on the day. Its 52-week range is ₹475.00 to ₹826.80.

What is the market cap of KRSNAA?

KRSNAA has a market capitalisation of about ₹1,656 crore. Its price-to-earnings ratio is 17.1.

How are KRSNAA's latest results?

KRSNAA reported revenue of ₹271 crore for Sep 2026, up 31.6% from a year earlier. Net profit was ₹25 crore (up 4.2% year on year). Return on equity was 10.3% in Mar 2026. Promoter holding was 27.11% in Sep 2026, down 0.13 points over 8 quarters.

Who owns KRSNAA?

As of Sep 2026, shareholding was: Promoter 27.11%, FII 3.84%, DII 14.5%, Public 54.54%.

How many mutual funds hold KRSNAA?

9 mutual fund schemes held KRSNAA in October 2026. That compares with 10 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 12 Sep 2025 · Final Dividend - Rs. 2.75
  • 13 Sep 2024 · Final Dividend - Rs. 2.5
  • 15 Sep 2023 · Final Dividend - Rs. 2.75
  • 15 Sep 2022 · Final Dividend - Rs. 2.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.